Global Medical Affairs Director, Bladder
Johnson & Johnson Innovative Medicine
Summary
The Global Medical Affairs Medical Director for bladder cancer will be responsible for leading aspects of the clinical-commercial optimization for bladder cancer assets under the guidance of the Sr Global Medical Affairs Leader (GMAL), Global Medical Affairs, Bladder.
Job description
They will partner closely with the Global Medical Affairs Medical Strategy and Execution team, Regional Medical TA/product leaders and Clinical Development Leader to support the development of integrated global medical affairs perspectives, strategies and plans.
The Medical Director will participate on the Global Commercial Team, 3M team, W-MAST and publication teams, and partner with the GMALs for the development of global medical affairs plans that reflects prioritized regional needs.
In addition, the Medical Director will support and partner with the Sr GMAL, Bladder Cancer and GMALs on the global publication plans, global opinion leader relations, global medical education and global advisory boards for our bladder cancer assets.
The Medical Director will collaborate closely with the Global MAF team in supporting the regional medical affairs representatives to develop integrated global medical affairs strategies and plans and maintain open, two-way communication to ensure regional medical affairs is up to date on all plans, progress and decisions.
The Medical Director will contribute to the overall integrated evidence generation activities within Global Medical Affairs for bladder cancer assets.
Responsible to ensure all global activities follow J&J Compliance principles, e.g. Health Care Compliance, etc.
Requirements
- Minimum of a masters level advanced scientific/medical degree (e.g. MD, PhD, PharmD, MPH or other masters level degree)
- Experience in solid tumors required with a strong preference for bladder experience
- Prior experience in a medical affairs role for 2+ years is required
- A minimum of 6-9 years of combined relevant experience in a medical/clinical environment, scientific function in the pharmaceutical industry is required
- Knowledge of TA products, both J&J and competitors, is required
- Experience working within and contributing to highly matrixed, cross-functional work teams comprised of high-level managers and executives is required
- A demonstrated track record of success within Medical Affairs, clinical environment and/or scientific function required
- Global mindset required
- Ability to partner cross culturally/regionally is preferred
- In-depth knowledge of study methodology, study data reviews and analysis
- Excellent knowledge of study execution, benefit risk management and lifecycle management
- Highly innovative with the ability to drive a complex and changing environment and effectively manage and resolve issues within the TA
- Strong experience developing and managing strategic relationships with medical experts/opinion leaders is highly desired
- Proven business understanding
- A minimum of 20% international travel is required
Benefits
- 401(k) Matching
- Pension Plan
- Long-term Incentive Program
- Vacation
- Sick Time
- Holiday Pay
- Floating Holidays
- Parental Leave
- Bereavement Leave
- Caregiver Leave
- Volunteer Leave
- Military Spouse Time-Off
Company overview
Johnson & Johnson Innovative Medicine is the pharmaceutical division of Johnson & Johnson, leading the way in medical innovation with a relentless focus on bringing transformational treatments to patients worldwide. The company applies rigorous science and compassion to address the most complex diseases of our time, developing groundbreaking medicines across key therapeutic areas including oncology, immunology, neuroscience, and cardiopulmonary medicine. With deep expertise and global reach, Johnson & Johnson Innovative Medicine reimagines how devastating diseases are treated and cured, delivering hope and better care for millions of patients and their families. The organization pioneers the path from laboratory research to clinical application, championing patients every step of the way while maintaining an unwavering commitment to scientific excellence and patient-centered innovation.